🔎 Trials Near Me

Почетна › Немалоклетни карцином плућа › Висконсин › Milwaukee

Kliničke studije za Немалоклетни карцином плућа u gradu Milwaukee, WI

Jedna studija za Немалоклетни карцином плућа traži učesnike na lokaciji u gradu Milwaukee ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Тражи се учесникФаза 3
  • Aurora St. Luke's Medical Center, Milwaukee
  • Aurora Cancer Care-Grafton, Grafton · 20 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Тражи се учесникФаза 3
  • UW Cancer Center at ProHealth Care, Waukesha · 17 ми удаљено
  • ProHealth D N Greenwald Center, Mukwonago · 25 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Тражи се учесникФаза 3
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Ascension Columbia Saint Mary's Hospital-Milwaukee Campus, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • и још 13
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Тражи се учесникФаза 1/2
  • Froedtert Hospital - Clinical Cancer Center, Milwaukee
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06914128

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Тражи се учесникФаза 1/2
  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT04198766

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Тражи се учесникФаза 3
  • Medical College of Wisconsin, Milwaukee
  • Drexel Town Square Health Center, Oak Creek · 11 ми удаљено
  • Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 ми удаљено
  • и још 4
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07388524

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Ascension Columbia St. Mary's, Milwaukee
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06793215

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Medical College of Wisconsin, Milwaukee
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06890598

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Тражи се учесникОпсервациона студија
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Ascension Columbia Saint Mary's Hospital - Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • и још 10
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06418204

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Тражи се учесникФаза 2
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • и још 5
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT03191149

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Тражи се учесник
  • Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT02984761

Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)

Тражи се учесникФаза 2
  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06305715

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • и још 5
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2/3
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • и још 5
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Froedtert Hospital/Medical College of Wisconsin, Milwaukee
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222566

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Тражи се учесникФаза 1
  • Exelixis Clinical Site #33, Milwaukee
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT05176483

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Тражи се учесникФаза 1
  • Research Site, Milwaukee
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT05877599

A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

Тражи се учесникФаза 2
  • Medical College of Wisconsin, Milwaukee
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT06855771

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Тражи се учесникФаза 3
  • Research Site, Milwaukee
Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2026. · NCT06350097

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • и још 4
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT05642572

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Milwaukee
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Studije za Немалоклетни карцином плућа u drugim gradovima

Ostale studije u gradu Milwaukee

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.